Get started
Author

Carol Matyka

Observed name: C Matyka
OpenAlex ID: A5065815573
A randomized phase III, double-blinded, placebo-controlled trial of aspirin as adjuvant therapy for breast cancer (A011502): The Aspirin after Breast Cancer (ABC) Trial
2022 · Wendy Y. Chen, Karla V. Ballman, et al. · Journal of Clinical Oncology · 15
ABC trial (A011502): A randomized phase III double-blinded placebo-controlled trial of aspirin as adjuvant therapy breast cancer.
2020 · Wendy Y. Chen, Eric P. Winer, et al. · Journal of Clinical Oncology · 5
ABC trial (A011502): Randomized phase III double blinded placebo controlled trial of aspirin as adjuvant therapy for breast cancer.
2018 · Wendy Y. Chen, Eric P. Winer, et al. · Journal of Clinical Oncology · 4
Association of higher baseline stress and pain with clinical outcomes: Secondary analysis from Alliance A011502.
2024 · Shipra Gandhi, Karla V. Ballman, et al. · Journal of Clinical Oncology · 2
PDF
Large numbers of patients are needed to obtain additional approvals for new cancer drugs: A retrospective cohort study
2023 · Charlotte Ouimet, Nora Hutchinson, et al. · Scientific Reports · 2
PDF
ABC trial (A011502): A randomized phase III double-blinded placebo controlled trial of aspirin as adjuvant therapy breast cancer.
2019 · Wendy Y. Chen, Eric P. Winer, et al. · Journal of Clinical Oncology · 2
ABC trial (A011502): A randomized phase III double blinded placebo controlled trial of aspirin as adjuvant therapy for node positive breast cancer.
2017 · Wendy Y. Chen, Eric P. Winer, et al. · Journal of Clinical Oncology · 2
Abstract P5-08-12: Association of Baseline Global Inflammation Score with Clinical Outcomes: Secondary Analysis from Alliance A011502
2025 · Shipra Gandhi, Karla V. Ballman, et al. · Clinical Cancer Research
Correlation of stress, depression, sleep, and pain with race and body mass index (BMI): Secondary analysis from Alliance A011502.
2024 · Shipra Gandhi, Karla V. Ballman, et al. · Journal of Clinical Oncology
PDF
Abstract P4-18-01: Sharing clinical trial results with patient participants: A project of the Dana Farber/Harvard Cancer Center (DF/HCC) breast cancer research advocacy group
2013 · ES Frank, KN Price, et al. · Cancer Research
Works count: 10
Citation count: 32
H-index: 3
I10-index: 1
Year
Topic
Type